EMRIS Pharma is developing a first-in-class topical drug to prevent skin toxicities caused by EGFR inhibitor antibodies in cancer patients.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Nazareth, Il
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.emris-pharma.com
- Keywords
- CytoReason.
- HQ
- Nazareth
Emris Pharma Questions
Emris Pharma's website is http://www.emris-pharma.com
Emris Pharma's LinkedIn profile is https://il.linkedin.com/company/emris-pharma
Emris Pharma has
6 employees.
View email and phone details for 6
employees at Emris Pharma.
Emris Pharma's industry is
Biotechnology Research
Emris Pharma's top competitors are
Levenberg Lab,
Evogene,
Cytoreason,
Memed,
Itay&beyond,
Pre-Cure,
Orsight Pharma Ltd,
Ub Therapeutics,
Ngt,
Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90).
Emris Pharma's categories are Biotechnology Research
Emris Pharma's founding year is 2023
